With the heroin epidemic rising, it seems wrong that the primary anti-overdose drug’s price is skyrocketing

Friday Sep 11th, 2015

The heroin epidemic is continuing to get worse around the U.S., and currently the anti-overdose drug naloxone is the main medication that can block the effects of opioids.

Amphastar Pharmaceuticals makes naloxone, and it has continued to increase the price as demand has gone up. It’s a business of course, and basically the only distributor of this kind of drug, so it makes sense that they want to (and can) make more profits. But when a drug is designed to save people’s lives in such dire circumstances, it is disconcerting that the rising price is now making it less available to the people who need it.

Read more at: http://medcitynews.com/2015/09/with-the-heroin-epidemic-rising-it-seems-...

Related Stories

Lead poisoning cases fell 19 percent in Baltimore last year, even as more children tested for exposure (Baltimore Sun)

The number of Baltimore children with lead poisoning fell 19 percent in 2017, even as more children were tested for exposure to the powerful neurotoxin.

Statewide, the number of Maryland children found to have elevated levels of lead in their blood held steady even as the number of children tested increased by 10 percent, according to a Maryland Department of the Environment report released Tuesday.

Read the entire story.

Azar Unveils Plan to Help Pregnant Patients Quit Opioids (MedPage Today)

States will get help from the federal government integrating services for pregnant and postpartum Medicaid patients with opioid use disorder under a pilot program announced Tuesday by Health and Hu

Trump declared an emergency over opioids. A new report finds it led to very little. (Vox)

To much fanfare last year, President Donald Trump ordered his administration to declare a public health emergency over the opioid epidemic. “As Americans, we cannot allow this to continue,” Trump said at the time. “It is time to liberate our communities from this scourge of drug addiction.”

When I’ve asked experts about these approaches, it’s not that any of them are bad. It’s that they fall short. For instance, Leana Wen, the former health commissioner of Baltimore (and soon-to-be president of Planned Parenthood), said that the Support for Patients and Communities Act “is simply tinkering around the edges.”

Read the entire story.

Visit the Newsroom